Basic Information

Dataset GSE63189
Status 2015-07-30
Species Homo sapiens
Source NCBI GEO
Subcellular Localization cytoplasm|nuclear|chromatin
PMID 26236012
Title Identification and functional characterization of long noncoding RNAs in breast cancer
Citation Sun M, Gadad SS, Kim DS, Kraus WL. Discovery, Annotation, and Functional Analysis of Long Noncoding RNAs Controlling Cell-Cycle Gene Expression and Proliferation in Breast Cancer Cells. Mol Cell 2015 Aug 20;59(4):698-711.
Experimental Design Prior to all treatments, the cells were grown for 3 days in phenol red-free MEM Eagle medium supplemented with 5% charcoal-dextran-treated calf serum. Cell fractionation - all treatments were performed for 180 min with 100 nM 17β-estradiol. Adherent cells were trypsinized, collected, and subsequently lysed in buffer A. The nuclei were collected by gentle centrifugation at 4°C and the resulting supernatant was collected as the cytoplasmic fraction. The nuclear pellet was washed twice with buffer A, each time accompanied by 10 strokes of douncing, to obtain clean and intact nuclei. The nuclei were then extracted with the sequential addition of low salt buffer and high salt buffer. The soluble extract was collected as the nuclear fraction. The remaining pellet was then resuspended in cell disruption buffer (PARIS kit, Ambion; AM1921), digested with DNase I (Roche), and centrifuged to remove any remaining insoluble material. The resulting supernatant was collected as the chromatin fraction. For lncRNA knockdown RNA-seq, transient RNAi-mediated knockdown of lncRNAs was performed by transfection of (1) siRNAs targeting selected lncRNAs and (2) commercially available control siRNA.

Sample Information

BioProject Sample Name Localization Treatment Source Label
PRJNA266932 GSM1543653 cytoplasmic fraction Untreated MCF-7 cells polyA+ RNA from the cytoplasmic fraction-E2, rep 1
PRJNA266932 GSM1543654 cytoplasmic fraction Untreated MCF-7 cells polyA+ RNA from the cytoplasmic fraction-E2, rep 2
PRJNA266932 GSM1543655 cytoplasmic fraction E2 treated MCF-7 cells polyA+ RNA from the cytoplasmic fraction+E2, rep 1
PRJNA266932 GSM1543656 cytoplasmic fraction E2 treated MCF-7 cells polyA+ RNA from the cytoplasmic fraction+E2, rep 2
PRJNA266932 GSM1543657 nuclear fraction Untreated MCF-7 cells polyA+ RNA from the nuclear fraction-E2, rep 1
PRJNA266932 GSM1543658 nuclear fraction Untreated MCF-7 cells polyA+ RNA from the nuclear fraction-E2, rep 2
PRJNA266932 GSM1543659 nuclear fraction E2 treated MCF-7 cells polyA+ RNA from the nuclear fraction+E2, rep 1
PRJNA266932 GSM1543660 nuclear fraction E2 treated MCF-7 cells polyA+ RNA from the nuclear fraction+E2, rep 2
PRJNA266932 GSM1543661 chromatin fraction Untreated MCF-7 cells polyA+ RNA from the chromatin fraction-E2, rep 1
PRJNA266932 GSM1543662 chromatin fraction Untreated MCF-7 cells polyA+ RNA from the chromatin fraction-E2, rep 2
PRJNA266932 GSM1543663 chromatin fraction E2 treated MCF-7 cells polyA+ RNA from the chromatin fraction+E2, rep 1
PRJNA266932 GSM1543664 chromatin fraction E2 treated MCF-7 cells polyA+ RNA from the chromatin fraction+E2, rep 2

Subcellular Localization Number

Note
RNA Type:
Condition:

Localization Differential Analysis

Note
RNA Type:
Localization:
Condition:
Method:
Enrichment:

Specific Subcellular Localization

Note
RNA Type:
Method:

Dynamic RNA Localization

Note
RNA Type:
Method:

Specific Enrichment Analysis

Note
RNA Type:
Localization:
Condition:
Method:
Enrichment:

Specific RNA Ratio

Note
RNA Type:
RNA Symbol:
TPM: